Cell Counting Kit-8 (CCK-8) |
Catalog No.GK10001 |
Cell Counting Kit-8 (CCK-8) is a ready-to-use one-bottle solution which offers a simple, rapid, reliable and sensitive measurement of cell viability and cytotoxicity of various chemicals.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2025):2413968.PMID:40223457
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Nat Commun 15.1 (2024):72.PMID:38167723
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Matter (2025).
- Adv. Fiber Mater. (2025):1-17.
- Acs Nano (2024).PMID:39361472
- ACS nano (2025).PMID:39846120
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Cancer Commun (2024).PMID:38512764
- Brain Behav Immun (2024).PMID:38565398
- Autophagy just-accepted (2024).PMID:39007910
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Nat. Commun. 16.1 (2025):2551.
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Adv Sci (2024):2401845.PMID:38757623
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Adv Sci (2023):2301107.PMID:37097746
- Acta Pharm Sin B (2025).
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2025):2413936.PMID:40047320
- Adv Sci (2025):2417374.PMID:40213972
- Adv Sci (2024):2404365.PMID:39159143
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2024):2402450.PMID:38952061
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Nano Today 61 (2025):102560.
- Water Res (2024):121379.PMID:38422694
- Biomaterials (2025):123335.PMID:40222258
- Small 21.3 (2025):2409121.PMID:39544127
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Adv Res (2023).PMID:36933884
- Small (2024):2407674.PMID:39363789
- Theranostics 12.7 (2022):3488.PMID:35547749
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Small Methods (2024):2400223.PMID:38602202
- Mater Horiz (2024).PMID:39189308
- Mol Ther (2025).PMID:39810420
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- J Hazard Mater (2024):135904.PMID:39303616
- Mater Horiz (2024).PMID:39189308
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Cell Discov 6.1 (2020):96.PMID:33349633
- Redox Biol 62 (2023):102663.PMID:36924682
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- J Adv Res (2025).PMID:40373960
- Redox Biol (2023):102983.PMID:38064762
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Adv Res (2025).
- J Control Release 360 (2023):647-659.PMID:37406817
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Environ Sci Technol (2024).PMID:39364562
- J Control Release 365 (2024):301-316.PMID:38007195
- Acta Biomater 157 (2023):321-336.PMID:36481504
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- J Control Release 349 (2022):254-268.PMID:35803328
- EBioMedicine 99 (2024).PMID:38101299
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Control Release 373 (2024):749-765.PMID:39084465
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Control Release 359 (2023):12-25.PMID:37244298
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Water Res (2024):122403.PMID:39278116
- Rare Met. (2025):1-23.
- Adv Healthc Mater (2025):2500845.PMID:40400499
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Cancer Lett (2024):216765.PMID:38408604
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- View-China (2025):20240103.
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Acta Biomater (2024).PMID:38452962
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Sci Total Environ 897 (2023):165514.PMID:37451464
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- ENGINEERING-PRC (2025).
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Food Chem (2024):139505.PMID:38703732
- Acs Appl Mater Inter (2024).PMID:38345297
- CANCER LETT (2025):217685.
- Mater. Today Bio (2025):101703.
- Brit J Cancer (2024):1-9.PMID:38594370
- J Colloid Interf Sci (2025):137652.
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Cancer Lett 611 (2025):217418.PMID:39725146
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Pharmacol Res (2024):107460.PMID:39393436
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- J Colloid Interf Sci (2025):.PMID:39755016
- Biomark Res 11.1 (2023):3PMID:36611218
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Acta Biomater (2025).PMID:39952883
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Front Immunol 14 (2023):1130308.PMID:37006248
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Environ Pollut 334 (2023):122148.PMID:37419204
- Acs Appl Mater Inter 15.32 (2023):38294-38308.PMID:37542453
- Acta Biomater (2025).PMID:40024424
- Environ Pollut 338 (2023):122581.PMID:37748638
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Cancer Lett (2024):217418.PMID:39725146
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Environ Res (2024):118221.PMID:38246300
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Phytomedicine 122 (2024):155091.PMID:37844378
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Phytomedicine 122 (2024):155091.PMID:37844378
- Front Immunol 16 (2025):1569210.PMID:40396173
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Phytomedicine 118 (2023):154944.PMID:37393830
- Phytomedicine (2023):155270.PMID:38096717
- Int. J. Biol. Macromol. (2025):143759.
- Int J Biol Macromol(2023):125130.PMID:37263336
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- CANCER IMMUNOL RES (2025).PMID:40323348
- Int J Biol Macromol (2024):129172.PMID:38176496
- Antivir Res 205 (2022):105381.PMID:35835291
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Int J Biol Macromol (2024):135979.PMID:39332550
- Int J Biol Macromol (2024):131928.PMID:38688339
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Int J Biol Macromol (2024):135562.PMID:39276884
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Acs Appl Mater Inter (2025).PMID:40025657
- Sci China Life Sci (2025):1-11.PMID:39821161
- Int J Biol Macromol (2025):140602.PMID:39922352
- Acs Appl Mater Inter (2024).PMID:39448903
- Int J Biol Macromol (2025):141767.
- Acs Appl Mater Inter (2025).PMID:39853325
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Acs Appl Mater Inter (2024).PMID:39320506
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol (2025):141146.PMID:39986528
- Nanoscale Horiz (2025).
- Mater Today Bio (2024):101019.PMID:38516170
- Int J Biol Macromol (2025):140632.PMID:39909240
- Int J Biol Macromol (2024):133667.PMID:38969038
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J Biol Sci 21.4 (2025):1837-1851.
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol (2024):137561.PMID:39537068
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Acs Sensors (2024).PMID:38958530
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- J Med Chem (2025).PMID:39842821
- Virol Sin (2023).PMID:37331658
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Front Immunol 13 (2022):902515.PMID:35874682
- Phytomedicine (2024):155859.PMID:38972239
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Front Immunol 13 (2022):986214.PMID:36341437
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Front Immunol 14 (2023):1111494.PMID:36817451
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Fertil Steril (2023).PMID:37178109
- Free Radical Bio Med (2024).PMID:38367927
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Int J Nanomed (2025):4535-4550.PMID:4023652
- J Gastroenterol (2023):1-14.PMID:37150773
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Front Nutr 9 (2022):812623.PMID:35419394
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Life Sci 308 (2022):120925.PMID:36057399
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Life Sci 312 (2023):121092.PMID:36279968
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Int J Nanomed 20 (2025):293-308.
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Food Res Int (2025):115940.
- Oncogene (2025):1-15.PMID:39920289
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- J Med Chem (2024).PMID:39292661
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- J Med Virol 97.3 (2025):e70267.
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Phytomedicine (2025):156860.
- J. Environ. Chem. Eng. (2025):116286.
- Cell Rep 44.3 (2025).PMID:39977268
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Phytomedicine 130 (2024):155744.PMID:38763011
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Front Immunol 14 (2023).PMID:37662906
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Phytother Res (2024).PMID:38558449
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Phytomedicine (2025):156598.
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Embo Rep (2025):1-23. PMID:40185977
- J Polym Environ (2025):1-16.
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Phytomedicine (2025):156515.PMID:39983438
- J Med Chem (2024).PMID:38315032
- AGING DIS 17.1 (2026):2.PMID:40072367
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Iscience (2025).
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Brit J Pharmacol (2024).PMID:38715438
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Exp Neurol 359 (2023):114266.PMID:36336032
- Biomater Adv (2024):214069.PMID:39447240
- J Agr Food Chem (2023).PMID:37922022
- Microbiol Res (2024):127927.PMID:39393129
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Life Sci (2024):122483.PMID:38307238
- Biochem Pharmacol (2024):116044.PMID:38336157
- Front Oncol 12 (2022):770628.PMID:35372056
- Acs Biomater Sci Eng (2024).PMID:38445959
- Acs Biomater Sci Eng (2024).PMID:38446137
- Am J Chinese Med (2024):1-23.PMID:38490807
- Mol Med 30.1 (2024):14.PMID:38254010
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Am J Physiol-Cell Ph (2024).PMID:38525543
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Immunol 15 (2024):1455996.PMID:39376562
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Front Oncol 12 (2022):858598.PMID:35321435
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Front Immunol 15 (2024):1375781.PMID:39391314
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Oncol 13 (2023):1120103.PMID:36959804
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Front Oncol 12 (2022):858598.PMID:35321435
- J Mater Chem B (2024).PMID:39119756
- Cells 11.23 (2022):3816.PMID:36497076
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Apoptosis (2024):1-19.PMID:39097858
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Cns Neurosci Ther (2023).PMID:37452510
- Int J Pharmaceut (2023):123142.PMID:37328119
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Lab Chip (2024).PMID:38939907
- Cells 11.24 (2022):4094.PMID:36552856
- Jci Insight (2024). PMID:38935435
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Biochem Pharmacol (2023):115632.PMID:37263300
- Front Immunol 15 (2024):1455996.PMID:39376562
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Mbio (2023):e01688-23.PMID:37882780
- Front Immunol 15 (2024):1375781.PMID:39391314
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Phytother Res (2023).PMID:37086359
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Resp Res 24.1 (2023):216.PMID:37674165
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Jci insight 9.15 (2024):PMID:38935435
- Phytother Res (2023).PMID:37246830
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Front Oncol 13 (2023):1132424.PMID:37251940
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- J Nutr Biochem (2024):109678.PMID:38844080
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Mol Cell Proteomics (2025):100930.PMID:40024376
- Apoptosis (2025):1-17.PMID:40347321
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Talanta (2025):127591.PMID:39847915
- MOL MED 31.1 (2025):126.PMID:40186145
- Front Immunol 16 (2025):1569210.
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Mol Med 31.1 (2025):1-15.PMID:40369420
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Front Immunol 16 (2025):1521965.PMID:40191190
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Biomacromolecules (2025).
- J Agr Food Chem (2025).PMID:40017402
- J Invest Dermatol (2025).PMID:39892773
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Front Pharmacol 12 (2021):610158.PMID:33762939
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Cancer Gene Ther (2021)1-12.PMID:33888871
- J Transl Med 23.1 (2025):131.PMID:39885513
- Int J Mol Med 55.3 (2025):1-17.
- Front Pharmacol 11 (2020):16.PMID:32140106
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Front. Immunol. 16 (2025):1556715.
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- J Agr Food Chem (2025).PMID:40152883
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Mol Med 31.1 (2025):1-15.PMID:40405066
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- J Agr Food Chem (2025).PMID:39962827
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Biomater Adv (2025):214257.PMID:40023084
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Mol Med 30 (2024):260.PMID:39707194
- Microbiol Res (2025):128183.
- J Invest Dermatol (2025).PMID:39892773
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Mol Carcinogen (2023).PMID:37750597
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Ethnopharmacol (2023):116731.PMID:37277084
- J Virol (2023):e00549-23.PMID:37222617
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- Am J Physiol-Gastr L (2024).PMID:38742280
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Transl Oncol 47 (2024):102042.PMID:38924847
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Molecules 28.6 (2023):2426.PMID:36985397
- Molecules 27.23 (2022):8568.PMID:36500666
- Food Funct. (2025).
- Nutrients 17.5 (2025):923.PMID:40077793
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Life Sci (2024):123148.PMID:39447733
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Molecules 27.17 (2022):5698.PMID:36080465
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Molecules 27.14 (2022):4603.PMID:35889477
- Clin Immunol (2024):110308.PMID:39002794
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- J Agr Food Res (2025):101694.
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Molecules 27.21 (2022):7183.PMID:36364008
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Exp Neurol (2025):115252.PMID:40221008
- Front Oncol 12 (2022):996080.PMID:36483054
- Environ Toxico (2024).PMID:38700384
- J Oncol 2022 (2022).PMID:36213838
- J Nutr Biochem (2024):109780.PMID:39395694
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Acs Appl Bio Mater (2024).PMID:38700956
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- J Drug Deliv Sci Tec 104 (2025) 106577.
- Life Sci 254 (2020):117793.PMID:32416164
- Front Endocrinol 13 (2022):998971.PMID:36147560
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Mol Neurobiol (2025):1-16.PMID:40402409
- Bioengineering 9.9 (2022):433.PMID:36134979
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- J Ethnopharmacol (2024):118080.PMID:38521426
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Transl Oncol 56 (2025):102396.PMID:40239242
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- J Ethnopharmacol (2024):119073.PMID:39522846
- J Ethnopharmacol (2024):118685.PMID:39127116
- Environ Toxicol (2023).PMID:38069587
- Int. J. Mol. Sci. 26.9 (2025):4325.
- J Ethnopharmacol (2024):119272.PMID:39716512
- Commun Biol 8.1 (2025):71.PMID:39820362
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- Glia (2024).PMID:39610064
- Front Oncol 12 (2022):1043161.PMID:36439418
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Front Oncol 12 (2022):961653.PMID:36457504
- J. Drug Delivery Sci. Technol. (2025):106841.
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- J Dent (2024):105436.PMID:39488296
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Macromol Biosci (2024):2400003.PMID:38597147
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- J Ethnopharmacol (2024):117958.PMID:38395179
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Biochem Pharmacol (2024):116688.PMID:39617210
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Toxicology (2024):154018.PMID:39608440
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Radiother Oncol (2024):110686.PMID:39709027
- ACS Appl. Nano Mater. (2025).
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- J Oncol 2022 (2022):6459029PMID:36199788
- J oncol 2022 (2022).PMID:36385962
- J Oncol 2022 (2022).PMID:36281290
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Mol Neurobiol (2024):1-18.PMID:38995443
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Biochem Pharmacol (2024):116438.PMID:39025409
- Macromol Biosci (2024):2400003.PMID:38597147
- Transl Oncol 52 (2025):102256.PMID:39733744
- J Ethnopharmacol (2024):117865.PMID:38369066
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- Food Biosci (2025):106564.
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- J Dent (2024):105436.PMID:39488296
- Cell Signal 113 (2024):110962.PMID:37931691
- Arch Toxicol (2024):1-16.PMID:38971901
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- J Oncol 2022 (2022).PMID:36213831
- Acs Biomater Sci Eng (2024).PMID:39164198
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Microorganisms 11.5 (2023):1268.PMID:37317242
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Colloid Surface B (2025):114537.PMID:39879672
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- Cell Signal (2023):110987.PMID:38029946
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- J Cancer 15.5 (2024):1397.PMID:38356722
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- J Neuro Oncol (2023):1-16.PMID:37351767
- Eur J Pharmacol (2024):176995.PMID:39277096
- Heliyon 8.11 (2022).PMID:36353164
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Endocrine (2024).PMID:38191984
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Cytokine 176 (2024):156507.PMID:38244240
- J Steroid Biochem (2023):106429.PMID:38035949
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- Gene (2023):148050.PMID:38042211
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- Oral Dis (2024).PMID:38168877
- Gerontology (2024).PMID:38168028
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Endocrine (2024):1-14.PMID:38378893
- Biol 14.6 (2025):594.
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Poultry Sci (2025):105339.
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Gene (2024):148399.PMID:38518902
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Cell Signal (2025):111815.PMID:40258578
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Frontiers in Pharmacology 16 (2025):1547685.
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Front Pharmacol 16 (2025):1517221.
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Eur J Pharmacol (2025):177497.PMID:40058753
- Zool Res 45.5 (2024):1001.PMID:39147715
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Front Oncol 14 (2024):1440906.PMID:39346724
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- J Biol Chem (2024):107499.PMID:38944125
- Sci Rep-Uk 15.1 (2025):794.
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Front. Pharmacol. 16 (2025):1545498.
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Brain Res Bull (2025):111245.PMID:39924054
- Environ Toxicol (2023).PMID:37052456
- Zool Res 45.5 (2024).PMID:39147715
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Pediatr Res (2024):1-10.PMID:38658662
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- J Inflamm Res (2024):10533-10546.PMID:39659750
- J Immunother (2024):10-1097.PMID:38847148
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- J Oncol 2022 (2022).PMID:35518787
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Brain Res Bull (2024):111165.PMID:39667505
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Front Oncol 14 (2024):1471109.PMID:39582546
- J Cancer 11.5 (2020):1162.PMID:31956362
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Bmc Complement Med 24 (2024).PMID:38783288
- J. Biomed. Mater. Res. Part A 113.3 (2025):e37893.PMID:40059713
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Front Genet 13 (2022):932973.PMID:36118847
- Heliyon (2024).PMID:38707472
- Neuroscience (2023).PMID:37286157
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Molecules 30.3 (2025):549.PMID:39942654
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Eur J Pharmacol (2025):177343.PMID:39900330
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Toxicol Sci (2024):kfae054.PMID:38636494
- Metabolomics 20.5 (2024):112.PMID:39369160
- Ann Transl Med 10.24 (2022).PMID:36660714
- Front Genet 13 (2022):959109.PMID:36147489
- Neurochem Res (2023):PMID:37127800
- Environ Toxicol (2024).PMID:39400944
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- S Afr J Bot 177 (2025):445-456.
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Heliyon (2024):.PMID:37461802
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Pathogens 14.2 (2025):182.
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Mol Med Rep 31.3 (2025):1-10.
- Dis Markers 2022 (2022).PMID:35845132
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Future Microbiol 0 (2024).PMID:38629914
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Shock 59.3 (2023):426-433.PMID:36609531
- Dis Markers 2022 (2022).PMID:35845132
- Technol Cancer Res T 19 (2020).PMID:33111613
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Tissue Cell (2024):102477.PMID:39018712
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Virus Res 313 (2022):198748.PMID:35304133
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Cell Transplant 33 (2024).PMID:38334047
- Mol Carcinogen (2025).PMID:40222040
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- J Mech Behav Biomed (2025):106963.
- Luminescence 39.1 (2024):e4671.PMID:38286599
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Clinics 77 (2022).PMID:35662010
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Shock (2023):10-1097.PMID:37179246
- WORLD J GASTRO ONCOL 17.3 (2025):102187.PMID:40092949
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- METABOLITES 15.5 (2025):290.
- Microb Pathogenesis (2024):107055.PMID:39442820
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Toxicon (2025):108293.PMID:39999927
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Microb Pathogenesis (2025):107720.PMID:40403987
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- CURR DRUG DELIV (2025).PMID:39976030
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Tissue Cell (2025): 102903.
- Biomarkers (2024):1-12.PMID:38568742
- Luminescence 40.2 (2025):e70116.PMID:39914999
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Toxicol Lett (2025).PMID:40412772
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Luminescence 40.2 (2025):e70095.PMID:39924164
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Gene 932 (2025):148898.PMID:39209182
- Hum Mol Genet (2024):ddae122.PMID:39216871
- J Sci Food Agr (2024).PMID:39394871
- Pathogens 14.2 (2025):182.
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Genomics (2025):111009.PMID:39864635
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Plos One 19.12 (2024):e0316362.PMID:39724098
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- ONCOL LETT 29.6 (2025):1-12
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Mol Biotechnol (2024):1-15.PMID:38771419
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Dis Markers 2022 (2022).PMID:35968506
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- Biochem Bioph Res Co (2025):151972.
- Shock (2023):10-1097.PMID:37988072
- J Mol Histol (2024):1-8.PMID:38758519
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Int J Chronic Obstr (2025):623-639.
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Tissue Cell 80 (2023):102001.PMID:36565506
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- J Int Med Res 48.4 (2020).PMID:31891283
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- TRANSL ANDROL UROL 14.2 (2025):36078-36378.PMID:40114844
- Immunobiology (2024):152832.PMID:38943814
- PeerJ 13 (2025):e19083.
- Chin J Integr Med (2024):1-11.PMID:38941045
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Cell J 25.8 (2023):554.PMID:37641417
- Cancer Biomark 42.5 (2025):18758592241306263.
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Oncol Res 33.1 (2024):103.PMID:39735676
- Particul Sci Technol (2025):1-13.
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- World J Oncol (2024):.
- J Int Med Res 48.4 (2020).PMID:31891283
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- J Int Med Res 49.3 (2021).PMID:33730930
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- J Obstet Gynaecol Re PMID:39169658
- Anim Biotechnol (2023):1-12.PMID:36756956
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Genes Genom (2023):1-15.PMID:37318704
- Hematology 28.1 (2023):2220522.PMID:37272581
- Fitoterapia (2024):106245.PMID:39393711
- Biochem Genet (2023):1-18.PMID:37148331
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Balk Med J 41.6 (2024).PMID:39319820
- J Obstet Gynaecol Re PMID:39169658
- Neuroreport 33.10 (2022):413.PMID:35623086
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Cell J 24.1 (2022):15.PMID:35182060
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Cell J 24.1 (2022):15.PMID:35182060
- Balk Med J 41.6 (2024):491.PMID:39319820
- Open Life Sci. 20.1 (2025):20221056.
- Comb Chem High T Scr (2024).PMID:35894460
- Chin J Integr Med (2025):1-10.PMID:40338446
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Mol Cell Probe (2025):102031.
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Vet Parasitol (2024):110284.PMID:39126893
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Vet Microbiol (2025):110495.
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Iran J Immunol (2023).PMID:37865874
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- J Herbs Spices Med P (2025):1-16.
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Crit Rev Eukar Gene (2025).
- Transpl P 52.1 (2020):398-405.PMID:31928781
- Bioact Mater 44 (2025):220-235.
- Drug Resist Update (2024):101161.
- Carbohyd Polym (2024):122897.
- Chin Herb Med (2024).
- Biosens Bioelectron (2024):116875.
- Int J Mol Sci 25.20 (2024):11184.
- Acs Omega (2024).
- Drug Des Dev Ther (2024):5841-5851.
- J Funct Foods 123 (2024):106621.
- Antioxidants 13.11 (2024) 1320.
- Antioxidants-Basel 13.11 (2024):1289.
- bioRxiv (2024) 2024-10.
- Ecotox Environ Safe 286 (2024):117233.
- Gene (2024) 149056.
- Front Pharmacol 15:1453938.
- New J Chem 48.11 (2024):5068-5073.
- Biomedicines 12.11 (2024):2543.
- Heliyon (2024).
- Faseb J 38.15 (2024):e23876.
- Heliyon (2024).
- Toxins 16.7 (2024):319.
- Am J Cancer Res (2024):2852-2867.
- Netw Model Anal Hlth 13.1 (2024):1-15.
- hLife (2024).
- J Transl Med 22.1 (2024) 1-16.
- Biomed Pharmacother 179 (2024):117370.
- Bioorg Chem (2024):107731.
- Phytother Res 34.4 (2020):836-845.
- Acs Appl Mater Inter (2024).PMID:39167710
- Small (2024):2402308.PMID:3911
- Viruses 16.8 (2024):1239.
- Int J Mol Sci 25.15 (2024):8340.
- Front Bioeng Biotech 12 (2024):1460870.
- J Tradit Compl Med (2024).
- Indian J Pharm Sci 86.3 (2024).
- Heliyon (2024).
- Acs Omega (2024).
- Nutrients 16.14 (2024):2346.
- Nutrients 16.14 (2024):2314.
- Rev Bras Farmacogn (2024):1-7.
- Acs Appl Nano Mater (2024).
- J Hazard Mater (2024) 135735.
- scienceasia (2024).
- Phytomedicine (2024):156091.
- J Hazard Mater (2024):136113.
- Chem Eng J (2024):156542.
- Pharmaceuticals-Base 17.10 (2024):1295.
- Int J Mol Sci 25.19 (2024):10496.
- Int J Mol Sci 25.19 (2024):10339.
- Adv Funct Mater 29.50 (2019):1906690.
- bioRxiv (2025):2025-01.
- J Transl Med 22.1 (2024):1-16.
- Front Pharmacol 15 (2024):1384141@0.jpg
- J Pharm Anal (2024):101053.
- Bioact Mater 36 (2024):524-540.
- Green Process Synth 13.1 (2024):20240050.
- J Nutr Biochem (2024):109769.PMID:9276944
- Int J Bioprinting (2024).
- Int J Biol Sci 20.12 (2024):4713-4730.
- Bioact Mater 43 (2025):32-47.
- J Integr Med-Jim (2024).
- Talanta (2024):126381.
- Front Oncol 12 (2022):851300.PMID:35392243
- Mol Cell Biochem (2024) 1-13.
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Appl Entomol Zool (2022):1-14.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Fiber Polym (2022):1-9.
- Biomed Res Int 2021 (2021).PMID:34373837
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- View-China 4.2 (2023):20220052.
- J Inflamm Res (2023):1045-1057.PMID:36936349
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- Cells 10.9 (2021):2399.PMID:34572049
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Nano Res (2022):1-8.
- Phytochem Lett 46 (2021):79-89.
- Int J Pept Res Ther 29.2 (2023):19.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Mol Med 29.1 (2023):6.PMID:36647009
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Sensor Actuat B-Chem 381 (2023):133437.
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- bioRxiv (2023):2023-05.PMID:37292976
- J Clean Prod 315 (2021):128201.
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Biomaterials 272 (2021):120757.PMID:33798960
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- bioRxiv (2022):2022-04.
- Phytomedicine 86 (2021):153565.PMID:33945919
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Exp Eye Res 209 (2021):108642.PMID:34058232
- J Inflamm Res 14 (2021):2445.
- HemaSphere 5.7 (2021).PMID:34136753
- Adv Funct Mater (2023):2214998.
- Oncol Lett 26.1 (2023):1-17.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Ceram Int 49.15 (2023):25953-25963.
- Food Hydrocolloid 120 (2021):106980.
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Aquaculture 564 (2023):739060.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- J Biol Chem 297.2 (2021).PMID:33722608
- Phytomedicine 103 (2022):154199.PMID:35679793
- Phytomedicine 105 (2022):154330.PMID:35905566
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Tissue Cell 76 (2022).PMID:35182988
- Mater Today Adv 15 (2022):100271.
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Foods 11.11 (2022):1575.PMID:35681325
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Acta Trop 232 (2022):106519.PMID:35584779
- Clin Transl Disc 2.2 (2022):e49.
- Nano Today 43 (2022):101416.
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- J Cancer 13.6 (2022):1808.PMID:35399733
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Oncol 2022 (2022).PMID:35909906
- Dis Markers 2022 (2022).
- Mater Today Chem 27 (2023):101331.
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- PeerJ 9 (2021):e11482.PMID:34820154
- Tissue Cell 74 (2022):101680.PMID:34808429
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Mol Cell Toxicol (2022):1-11.
- Cells 11.22 (2022):3580.PMID:36429010
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Cancers 14.21 (2022):5218.PMID:36358640
- Nano Today 41 (2021):101326.
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Cancers 14.19 (2022):4645.PMID:36230568
- Molecules 27.16 (2022):5337.PMID:36014573
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Bio-Des Manuf 5.2 (2022):358-370.
- J Oncol 2022 (2022).PMID:36059813
- Viruses 14.8 (2022):1783.PMID:36016405
- Phytochem Lett 47 (2022):174-179.
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Front Pharmacol 11 (2021):618262.PMID:33551818
- J Cancer 15.13 (2024):4244-4258.
- New J Chem (2024).
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Exp Ther Med 27.5 (2024):1-16.
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Mater Design (2024):112812.
- J Funct Foods 114 (2024):106076.
- Front Immunol 15 (2024):1326137.
- Antioxidants Basel 13.3 (2024):264.
- Kaohsiung J Med Sci (2024).PMID:38340032
- J Agr Food Chem (2024).
- Mater Res Express 7.2 (2020):025401.
- J Ethnopharmacol (2024):117867.PMID: 38342155
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1347683.PMID:38343537
- bioRxiv (2024):2024-02.
- Mater Today Bio (2024):100958.
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Mol Ther Nucl Acids (2020).
- Int J Mol Sci 25.2 (2024):919.
- ACS Appl. Eng. Mater. (2025).
- Cell Biomaterials (2025):
- Nanoscale (2024).
- Phytomedicine (2024):155347.
- bioRxiv (2024):2024-05.
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Heliyon (2024).
- Pharmaceutics 16.6 (2024):744.
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- Theranostics 14.7 (2024):2687.
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Phytomedicine (2024):155744.
- Adv Funct Mater (2024):2400489
- Mater Express 10.1 (2020):102-111.
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Acs Pharmacol Transl (2024).
- Heliyon (2024).
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Sensors & Diagnostics (2024).
- Adv Funct Mater (2024):2305827.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Front Oncol 10 (2020):387.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Crystals 13.7 (2023):1067.
- Appl Entomol Zool 58.4 (2023):303-313.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Iscience 26.9 (2023).PMID:37670789
- Front Microbiol 14 (2023).PMID:37645224
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Mol Ther-Nucl Acids (2020).
- Nanophotonics 11.22 (2022):5089-5100.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Front Mar Sci 9 (2022):861117.
- Chem Eng J 474 (2023):145358.
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Adv Funct Mater (2023):2309690.
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Food Sci Nutr (2023).
- Biocell 47.8 (2023).
- Ann Hematol (2023):1-12.
- Crit Rev Eukar Gene 34 (2024).
- Front Immunol 14 (2023).PMID:37901236
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Biochip J (2023):1-10.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Cell Toxicol (2023):1-10.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Int J Mol Sci 25.24 (2024):13439.
Cell Counting Kit-8 (CCK-8) allows convenient assays using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(
Cell Counting Kit-8 allows sensitive colorimetric assays for the determination of the number of viable cells in the proliferation and cytotoxicity assays. The detection sensitivity of CCK-8 is superior to that of other tetrazolium salts, including MTT, XTT, and MTS.
Figure 1: Working mechanisms of Cell Counting Kit-8 (CCK-8).
Cell Number Determination
1. Inoculate cell suspension (100 μL/well) in a 96-well plate. Pre-incubate the plate in a humidified incubator (e.g., at 37°C, 5% CO2).
2. Add 10 μL of the CCK8 solution to each well of the plate. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
3. Incubate the plate for 1 - 4 hours in the incubator.
4. Measure the absorbance at 450 nm using a microplate reader.
Cell Proliferation and Cytotoxicity Assay
1. Seed cells in a 96-well plate at a density of 103-104 cells/well in 100 μL of culture medium to be tested. Culture the cells in a CO2 incubator at 37°C for 24 hours.
2. Add various concentrations of substances to be tested to the plate.
3. Incubate the plate for an appropriate length of time (e.g., 6, 12, 24 or 48 hours) in the incubator.
4. Add 10 μL of CCK8 solution to each well of the plate using a repeating pipettor. Be careful not to introduce bubbles to the wells, since they interfere with the O.D. reading.
5. Incubate the plate for 1 - 4 hours in the incubator.
6. Before reading the plate, it is important to mix gently on an orbital shaker for 1 minute to ensure homogeneous distribution of color.
7. Measure the absorbance at 450 nm using a microplate reader.
Data Analysis
There are several ways to do statistical analysis. You can choose to use O.D. values or cell numbers. We offer one of them.
Cell viability (%) = [(As-Ab) / (Ac-Ab)] × 100
Inhibition rate (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbance of the experimental well (absorbance of cells, medium, CCK8 and wells of the test compound).
Ab = blank well absorbance (absorbance of wells containing medium and CCK8).
Ac = control well absorbance (absorbance of wells containing cells, medium and CCK8).
Making a standard curve
1. The cell counting plate counts the number of cells in the cell suspension.
2. Using the medium, the cell suspension is diluted to a concentration gradient, usually requiring 5-7 concentration gradients, several replicate wells per group. Then inoculate the cells. (Note the number of cells per well. If you are diluting the cell suspension in a tube, carefully mix the cells again before adding the wells to the plate. The volume of the cell suspension in each well should be the same.)
3. Incubate until the cells are adherent (usually 2-4 hours), then add 10 μl of CCK8 per 100 μl of medium. Incubation was continued for 1-4 hours, and the absorbance at 450 nm was measured with a microplate reader. Make a standard curve with the number of cells as the X-axis coordinate and the O.D. value as the Y-axis coordinate.
The number of cells of the sample to be tested can be determined based on the curve. A prerequisite for using this standard curve is that the culture conditions are the same.
Precautions
1. Make sure the drug and CCK8 are evenly distributed in the medium.
2. The more cells proliferate, the darker the color; the stronger the cytotoxicity, the lighter the color.
3. For adherent cells, at least 1000 cells per well (100 μl medium). For leukocytes, at least 2500 cells per well (100 μl medium) are required due to their low sensitivity. The recommended 96-well plate has a maximum cell count of 25,000 per well. If the test is performed using a 24-well or 6-well plate, calculate the corresponding number of cells per well and adjust the volume of CCK8 to 10% of the total liquid volume per well.
4. Since the CCK8 assay is based on dehydrogenase activity in living cells, conditions or chemicals that affect dehydrogenase activity may result in a difference between the actual number of viable cells and the number of viable cells measured using CCK8.
5. WST-8 may react with a reducing agent to form WST-8 formazan. If a reducing agent (such as some antioxidants) is used, it will interfere with the test. If more reducing agent is present in the system to be tested, it is necessary to remove it.
6. After 2 hours of incubation, the background O.D. value is typically 0.1-0.2 units.
7. Be careful not to introduce air bubbles into the holes as they will interfere with the O.D. value.
8. If you want to sterilize the CCK8 solution, use a 0.2 μm membrane filter solution.
9. The incubation time will vary depending on the type and amount of cells in the well. Generally, leukocytes are less colored and may require longer incubation times (up to 4 hours) or large numbers of cells (~105 cells/well).
10. If there is high turbidity in the cell suspension, measure and subtract the O.D value of the sample at 600 nm or higher.
11. CCK8 cannot be used for cell staining.
12. The phenol red in the medium does not affect the experimental results. The absorbance of phenol red can be eliminated by subtracting the absorbance of the background in the blank hole during calculation, so it will not affect the detection.
13. The toxicity of CCK8 is very low. After the CCK8 assay is completed, the same cells can be used for other cell proliferation assays, such as crystal violet assay, neutral red assay or DNA fluorescence assay. (Unless the cells are extremely rare, it is not recommended.)
14. This kit can be used in E. coli but not in yeast cells.
15. Before reading the plate, you can mix gently on the shaker.
16. We recommend inoculation of cells in wells near the center of the plate. The medium in the outermost circle of holes is easily evaporated and can be filled with PBS, water or medium.
17. If you don't have a 450 nm filter. You can also use filters with absorbance between 430 and 490 nm, and 450 nm filters for optimum sensitivity.
18. Measure the absorbance at 450 nm. If you need to make a dual wavelength measurement, the absorbance at 650 nm can be determined as the reference wavelength.
19. The presence of metal ions in the drug may affect the sensitivity of CCK8. Lead chloride, iron chloride, and copper sulfate at a final concentration of 1 mM inhibit 5%, 15%, and 90% of the color reaction, reducing sensitivity. If the final concentration is 10 mM, it will be 100% inhibited.
Applications |
1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
Shipping | Ship with blue ice. |
Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
Usage | For research use only! Not for use on humans. |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.
Average Rating: 5
(Based on Reviews and 420 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *